Interestingly, MALAT1 expression was induced by IL-1β treatment and during the progression of hyperglycaemia in the non-obese diabetic (NOD) T1D mouse model, indicating that this lncRNA might play a role in the decline of β-cell function during the progression of T1D. The gene discussed is IL1B; the disease is type 1 diabetes mellitus.